Cancer Diagnostics | Evaluate

Epigenomics goes private

January 21, 2016

The medtech IPO window swings shut

January 20, 2016

Asco-GI preview – Lutathera delivers again

October 28, 2015

GE downplays Clarient sale

October 07, 2015

Double whammy is Exactly the wrong prescription for Cologuard

February 16, 2015

Interview – Guardant Health takes $50m to make biopsy a thing of the past

August 12, 2014

Exact Sciences set for US reimbursement after Cologuard approved

February 05, 2014

Myriad impresses with sales past and future

August 07, 2013

Ambry Genetics could end up benefiting from Myriad lawsuit

June 30, 2011

BIO 2011 – Diagnostics want barriers to compensation torn down